M2 macrophages play a critical role in the tumor microenvironment of invasive solid tumors. They are closely associated with perineural invasion (PNI) and are often linked to poor prognosis. In this context, tumor-derived exosomes serve as important mediators of intercellular communication. However, the relationship between tumor cell-induced M2 macrophages and PNI in cholangiocarcinoma remains unexplored. In this study, we utilized multiplex immunofluorescence and transcriptomic sequencing to demonstrate the upregulation of LINC01812 in cholangiocarcinoma tissues and its positive correlation with M2 macrophage infiltration. Exosomal lncRNA sequencing, exosome uptake experiments, RNA pull-down assays, and mass spectrometry analysis demonstrated that macrophages can internalize exosomal LINC01812 and promote the M2 phenotype in cholangiocarcinoma cells. Additionally, Transwell and in vitro cocultures with the dorsal root ganglia confirmed that the tumor microenvironment significantly enhances the nerve infiltration of cholangiocarcinoma cells via M2 macrophages. The findings of this study indicate that exosomes containing LINC01812 derived from cholangiocarcinoma can induce M2 macrophage polarization and facilitate nerve infiltration, thereby providing new potential therapeutic targets for managing PNI in cholangiocarcinoma.
9 November 2024 in European Journal of Surgical Oncology
The research aimed to create and verify a nomogram model that can predict the likelihood of cholangiocarcinoma with microvascular invasion (MVI). The clinical data of 476 patients with surgically confirmed cholangiocarcinoma were collected retrospectively. This included 240 cases of intrahepatic cholangiocarcinoma (iCCA), 85 cases of perihilar cholangiocarcinoma (pCCA), and 151 cases of extrahepatic cholangiocarcinoma (eCCA). Using this data, we conducted forward multivariate regression analysis to identify the factors that influence the risk of preoperative MVI in patients with cholangiocarcinoma. And using these variables, we developed three nomogram models. The variables in the model for predicting MVI of iCCA were lymph node metastasis, distant metastases, carcinoembryonic antigen, and tumor size, all of which had a significance level of P < 0.05. The internal and external validation consistency index (C-index) were 0.831 and 0.781, respectively. The variables in the model for predicting MVI of pCCA were lymph node metastasis, carcinoembryonic antigen, and tumor size, all of which had a significance level of P < 0.05. The internal and external validation consistency index (C-index) were 0.791 and 0.747. And the variables in eCCA were lymph node metastasis, distant metastases, carcinoembryonic antigen, and tumor size, all of which had a significance level of P < 0.05. The internal and external validation consistency index (C-index) were 0.834 and 0.830. we have developed and validated a preoperative nomogram model for predicting MVI in patients with iCCA, pCCA, and eCCA.
Perineural invasion (PNI) is a major contributor to the aggressiveness and poor prognosis of cholangiocarcinoma (CCA). However, the crosstalk among tumor cells, the peripheral nervous system, and tumor-associated macrophages (TAMs) within the tumor microenvironment (TME) remains incompletely defined. Using in vitro and in vivo models of PNI, we demonstrate that tumor-derived exosomal LINC01978 mediates neural reprogramming and TAM-associated extracellular matrix (ECM) remodeling. Subsequent analyses of clinical cohorts confirm that high LINC01978 expression is significantly associated with PNI and poorer survival. This mechanism is further validated in human specimens by IHC and IF. Mechanistically, we propose a nerve-coupled dual-loop model that drives PNI in CCA. In the first loop, tumor-derived exosomes deliver LINC01978 to neural cells. This process promotes neurite outgrowth via autocrine glial cell line-derived neurotrophic factor (GDNF) signaling, which in turn activates the RET/STAT3 signaling pathway in CCA cells, thereby promoting malignant phenotypes. After this loop is established, a second loop emerges at the invasive front. Invaded nerves secrete CCL2, thereby preferentially recruiting CCR2+ inflammatory monocytes (IMs) to PNI sites, where they differentiate into TAMs and secrete CTSB to degrade the perineural ECM. Together, the two loops act sequentially and reinforce each other, creating a self-amplifying program that escalates PNI.